about
Electrophysiological effects of trace amines on mesencephalic dopaminergic neuronsProfile of gantenerumab and its potential in the treatment of Alzheimer's diseaseReelin haploinsufficiency reduces the density of PV+ neurons in circumscribed regions of the striatum and selectively alters striatal-based behaviorsN-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptorsInhibition of catechol-O-methyltransferase (COMT) in the brain does not affect the action of dopamine and levodopa: an in vitro electrophysiological evidence from rat mesencephalic dopamine neuronsEnhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPaseA2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activationDysfunctional dopaminergic neurotransmission in asocial BTBR mice.Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease.Serotonin impairment in CSF of PD patients, without an apparent clinical counterpartFree D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammalsMetabotropic glutamate receptor 1 mediates the electrophysiological and toxic actions of the cycad derivative beta-N-Methylamino-L-alanine on substantia nigra pars compacta DAergic neurons.Trace amines depress D(2)-autoreceptor-mediated responses on midbrain dopaminergic cells.Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes.Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.Trace amines depress GABA B response in dopaminergic neurons by inhibiting G-betagamma-gated inwardly rectifying potassium channels.Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons.Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.Acute action of rotenone on nigral dopaminergic neurons--involvement of reactive oxygen species and disruption of Ca2+ homeostasis.The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction?Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release.Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons.Continuous Positive Airway Pressure Treatment Increases Serum Vitamin D Levels in Male Patients with Obstructive Sleep ApneaThe mechanism of amphetamine-induced inhibition of rat substantia nigra compacta neurones investigated with intracellular recording in vitro.Dopamine-containing neurons are silenced by energy deprivation: a defensive response or beginning of cell death?Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats.Optic Nerve Dysfunction in Obstructive Sleep Apnea: An Electrophysiological Study.On the effects of psychostimulants, antidepressants, and the antiparkinsonian drug levodopa on dopamine neurons.Synaptic plasticity in the basal ganglia: a similar code for physiological and pathological conditions.The midbrain slice preparation. An in vitro model to select potential anti-parkinsonian drugs?Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitisParadoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidateL-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease?Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia.Targeting synaptic dysfunction in Alzheimer's disease therapy.Review: Parkinson's disease: from synaptic loss to connectome dysfunction.The role of adiponectin receptors in the regulation of synaptic transmission in the hippocampus.Vitamin D status of male OSAS patients improved after long-term CPAP treatment mainly in obese subjects.Current Concepts on the Physiopathological Relevance of Dopaminergic ReceptorsPINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity.
P50
Q21129325-35D6BE99-648C-4700-8691-458A30F121E5Q27027675-90797B7A-1E2B-4624-80FC-1E3892BBA06AQ28237853-10089CEB-725C-45F9-8E30-322FA826AC05Q28244889-697AFA58-8365-4543-9D6B-93283DCB2D6EQ28369356-AED639A4-F8B4-412C-B553-EA63CD3F34FBQ28509076-297F48B1-7C49-4F42-9C93-85417C687236Q28728678-BF67658F-3BCC-4E3A-9070-4FB1D123D724Q30586693-5C30B786-AE56-4897-8068-6B3B3D8CD712Q30844298-A982A20C-548E-4457-A3F6-EE7BDEAD570EQ33921178-25E03BA0-A582-4D2E-8BF8-EEB739F08F50Q33990671-E3F18DBC-B15B-4399-9D7F-741CC9043CEDQ34022060-21BED441-53BA-4518-9DB2-38066C4999BDQ34123376-ACBBBE1A-4A58-4D65-8AF6-979D4AEBAC95Q34332352-E9AF03CE-AA17-4A7C-9F07-F2180028583BQ34337014-AACF3C67-B592-471F-A134-E58A3BAA517BQ34383682-440BB4F9-4DFB-40E9-A2C4-A6A8236CB553Q34543525-A16EE802-FE73-4DA5-9C01-6D8A8AE92BE6Q34565099-BCEF1B5D-F28A-4E81-8EDB-44237F517DB1Q35012808-29C62051-7266-49CE-86C1-6EB99ACB54DFQ35111634-94409905-D894-4617-8CC0-F39D3A165DB8Q35169645-33CCEF9A-4B68-4FC0-9C91-14E0EBD8E50BQ35285315-CA37EE61-B090-491B-88E6-812BF9EF9265Q35640434-14AD91C1-08A2-448D-ACD6-80D9385DA948Q35756737-D11840BB-B31C-432F-AEA6-4FDF92E0FF3EQ36142758-3AF66EA8-F1EC-44BB-A213-9BBC7758CCAAQ36172332-0D21A738-3FDB-45E0-818B-9E6B1FC2EE39Q36369710-AEC7D3BA-804A-4FCB-8868-6606370270A6Q36653973-D05636CF-8C1A-4B70-A551-DC8198083AE1Q37075099-98CA03B9-A5AC-4680-9101-57DFA5E3F813Q37201158-E7935FAB-8966-48EA-849A-CA82E54C6493Q37228420-27952FD0-83FB-4E78-9FAE-ACC5B49A618FQ37428628-36561FEB-5F7B-4ECC-89DB-54C8A2B98FC2Q37896951-210DBCF4-3CDD-4784-85F8-AC62F1F08E2EQ37986853-89ACA3DE-110C-46C0-9A4F-26A6408AED07Q38036916-CE1244BC-877A-4F9A-AF84-A57EDA3DCD31Q38650395-ECA77214-14C2-4AE7-BCAC-BE09E4EFB8EBQ38967040-BB966F62-20A0-44A3-B1C9-9A400021FBF6Q39104419-428D3A3C-EFD4-41BE-AB98-90FFE2B183EEQ39147170-F3850A7D-C632-4226-86C2-78BF731C7113Q39647087-A01C655C-C6B9-4113-82E9-B883D303842E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nicola B. Mercuri
@ast
Nicola B. Mercuri
@en
Nicola B. Mercuri
@es
Nicola B. Mercuri
@nl
Nicola B. Mercuri
@sl
type
label
Nicola B. Mercuri
@ast
Nicola B. Mercuri
@en
Nicola B. Mercuri
@es
Nicola B. Mercuri
@nl
Nicola B. Mercuri
@sl
prefLabel
Nicola B. Mercuri
@ast
Nicola B. Mercuri
@en
Nicola B. Mercuri
@es
Nicola B. Mercuri
@nl
Nicola B. Mercuri
@sl
P1053
K-5348-2016
P106
P1153
7004633884
P1960
HKxf-BUAAAAJ
P21
P31
P496
0000-0001-6700-7491